Sabbin Magunguna don Cututtuka masu kumburi

A KYAUTA Kyauta 4 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Morningside Ventures a yau ta sanar da ƙaddamar da Adiso Therapeutics, wani kamfani na ilimin kimiyyar halittu na asibiti wanda ke haɓaka bututun sabbin hanyoyin kwantar da hankali da ke niyya da cututtukan kumburi. Morningside ya ba da kuɗin tsare-tsaren ci gaban Adiso har zuwa yau, tare da shirye-shiryen kara tallafawa ci gaban kamfanin na ci gaba.     

Adiso yana haɓaka sabon bututun ƙananan ƙwayoyin cuta tare da sabbin hanyoyin aiwatar da aiki da nau'in nau'ikan samfuran biotherapeutic guda ɗaya (SS-LBP), suna bin alamun gubar a cikin ulcerative colitis (UC), da C. Difficile infection (CDI). Baya ga shirye-shirye guda biyu na Phase 1 (UC & CDI) da kuma shirin 2 na lokaci (UC), Adiso yana haɓaka wani sabon shiri mai kumburi a cikin lokacin ganowa wanda aka fara bincikar shi a cikin kumburin numfashi, tare da yankuna masu yuwuwar hanyoyin warkewa na gaba don bi.

Kamfanin ya ƙunshi ma'aikata 25 waɗanda a baya, a ƙarƙashin laima na Morningside, sun sami nasarar buɗe sabbin Magungunan Bincike guda uku (INDs) kuma sun gabatar da takaddun haƙƙin mallaka tare da samun Nazari na Fast Track na Amurka, wanda a ƙarshe ya kai ga samuwar Adiso. Adiso zai yi aiki a karkashin jagorancin Babban Jami'in Gudanarwa na kwanan nan, Scott Megaffin. Mista Megaffin ya mallaki fiye da shekaru 30 na ƙwarewar masana'antu da kuma samun nasara a cikin manyan ayyukan jagoranci a Bristol-Myers Squibb, Pfizer, Schering-Plough, Adolor, Onconova, da Churchill. Kwanan nan, Mista Megaffin ya yi aiki a matsayin Shugaba na Adastra Pharmaceuticals, kamfanin haɓaka matakin asibiti na oncology, inda ya jagoranci kamfanin zuwa ga cin nasara ma'amala tare da Cothera Bioscience a cikin Oktoba 2021.  

"Mahimman buƙatun likita waɗanda ba a cika su ba sun wanzu don sabbin hanyoyin kwantar da hankali waɗanda ke yin niyya ga tushen ilimin halittu na cututtukan kumburi ba tare da haifar da tsarin rigakafi ba," in ji Jason Dinges, Shawarar Fasaha ta Morningside da Memba na Hukumar Adiso. “Adiso yana gudu daga bakin kofa tare da shirye-shiryen asibiti guda uku masu ban sha'awa don maganin ulcerative colitis da rigakafin CDI mai maimaitawa. Mun yi imanin cewa a ƙarƙashin jagorancin Scott kuma tare da ƙwararrun ƙwararrun masu haɓaka magunguna, Adiso yana shirin yin nasara.

"A Adiso muna magance cututtuka masu kumburi tare da hanyoyi daban-daban da kuma kwarin gwiwa. Muna tunanin sabon gaskiya ga marasa lafiya, yin amfani da sanannun ci gaban hanyoyin kwantar da hankali na ƙwayoyin cuta waɗanda ke yin alƙawarin sake fasalin tsarin rigakafi na mai watsa shiri, ta yadda cutar kumburin da ke ciki ba ta da ƙarfi ko kuma mara lafiya ya zama mai rigakafi, ”in ji Scott Megaffin, Shugaba na Adiso Therapeutics. . "Na yi farin ciki da jagorantar irin wannan tawaga ta musamman, mai daraja ta duniya, kuma ta sadaukar da kai a Adiso a cikin haɓaka waɗannan hanyoyin kwantar da hankali na musamman waɗanda aka tsara don dakatar da dysregulation da kumburi ke haifarwa."

Mustafa A. Noor, MD, FACP shi ma ya shiga tawagar Adiso jagoranci. Dokta Noor ya ɗauki matsayi na Babban Jami'in Harkokin Kiwon Lafiyar Jama'a, yana kawo fiye da shekaru 20 na ƙwarewar ci gaban ƙwayoyi a cikin yankuna masu yawa na warkewa a farkon-zuwa tsakiyar mataki da kamfanonin duniya ciki har da AMAG Pharmaceuticals, Akcea Therapeutics, Ipsen, Pfizer, Glaxo-Smith Kline. , da kuma Bristol Myers Squibb.

“Tsarin ciwon kumburi shine tsakiyar manyan cututtuka da yawa kuma barnar da yake haifar da lahani ga lafiya da jin daɗin marasa lafiya. Zaɓuɓɓukan jiyya na yanzu ba su isa ba don dakatar da ci gaba da cututtuka da inganta rayuwar rayuwa a cikin aminci da ma'ana, "in ji Dokta Noor, CMO na Adiso Therapeutics. “Halayen musamman na babban fayil na Adiso don maganin cututtukan kumburi suna da yuwuwar a ƙarshe su zama magunguna masu mahimmanci ga marasa lafiya. Gina kan ingantaccen karatun asibiti da na farko har zuwa yau, Ina fatan in jagoranci matakai na gaba na ci gaban asibiti na fayil ɗin mu tare da ƙwararrun ƙungiyar masu haɓaka asibiti."

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...